The effect of systemic anti-tumor necrosis factor-alpha treatment on Porphyromonas gingivalis infection in type 2 diabetic mice

Archives of Oral Biology

Volumn 55, Issue 5, 2010, Pages 379-384

  Takano, Mayuko ^a   Nishihara, Rieko ^a   Sugano, Naoyuki ^a   Matsumoto, Kazuma ^a   Yamada, Yutaka ^a   Takane, Masatoshi ^a   Fujisaki, Yoshiaki ^a   Ito, Koichi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Anti TNF antibody; Diabetes mellitus; IL 6; Porphyromonas gingivalis; TNF

Indexed keywords

ANTIBODY; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BACTEROIDACEAE INFECTION; BLOOD; C57BL MOUSE; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RAT;

ANIMALS; ANTIBODIES; BACTEROIDACEAE INFECTIONS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; INJECTIONS, INTRAVENOUS; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS; PORPHYROMONAS GINGIVALIS; RATTUS;

EID: 77950860588     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2010.03.004     Document Type: Article

References (36)

1. Argilés J.M., López-Soriano J., and López-Soriano F.J. Cytokines and diabetes: the final step? Involvement of TNF-α in both type I and II diabetes mellitus. Horm Metab Res 26 (1994) 447-449
2. Lang C.H., Dobrescu C., and Bagby G.J. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130 (1992) 43-52
3. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., and Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271 (1996) 665-668
4. Kroder G., Bossenmaier B., Kellerer M., Capp E., Stoyanov B., Mühlhöfer A., et al. Tumor necrosis factor-α- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 97 (1996) 1471-1477
5. Bruun J.M., Verdich C., Toubro S., Astrup A., and Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α. Effect of weight loss in obese men. Eur J Endocrinol 148 (2003) 535-542
6. Mishima Y., Kuyama A., Tada A., Takahashi K., Ishioka T., and Kibata M. Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Res Clin Pract 52 (2001) 119-123
7. Fernandez-Real J.M., Lainez B., Vendrell J., Rigla M., Castro A., Peñarroja G., et al. Shedding of TNF-α receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 282 (2002) E952-E959
8. Lechleitner M., Herold M., Dzien-Bischinger C., Hoppichler F., and Dzien A. Tumour necrosis factor-α plasma levels in elderly patients with type 2 diabetes mellitus-observations over 2 years. Diabetes Med 19 (2002) 949-953
9. Hugoson A., Thorstensson H., Falk H., and Kuylenstierna J. Periodontal conditions in insulin-dependent diabetics. J Clin Periodontol 16 (1989) 215-223
10. Nelson R.G., Shlossman M., Budding L.M., Pettitt D.J., Saad M.F., Genco R.J., et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 13 (1990) 836-840
11. Emrich L.J., Shlossman M., and Genco R.J. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 62 (1991) 123-131
12. Oliver R.C., and Tervonen T. Periodontitis and tooth loss: comparing diabetics with the general population. J Am Dent Assoc 124 (1993) 71-76
13. Grossi S.G., Zambon J.J., Ho A.W., Koch G., Dunford R.G., Machtei E.E., et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 65 (1994) 260-267
14. Papapanou P.N. Periodontal diseases: epidemiology. Ann Periodontol 1 (1996) 1-36
15. Nishimura F., Iwamoto Y., Mineshiba J., Shimizu A., Soga Y., and Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-α in a 2-way relationship. J Periodontol 74 (2003) 97-102
16. Graves D.T. The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis 28 (1999) 482-490
17. Bretz W.A., Weyant R.J., Corby P.M., Ren D., Weissfeld L., Kritchevsky S.B., et al. Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population. J Am Geriatr Soc 53 (2005) 1532-1537
18. Engebretson1 S., Chertog R., Nichols A., Hey-Hadavi J., Celenti R., and Grbic J. Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes. J Clin Periodontol 34 (2007) 18-24
19. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
20. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95 (1995) 2409-2415
21. Grimble R.F. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5 (2002) 551-559
22. Fernández-Real J.M., and Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24 (2003) 278-301
23. Iwatsuka H., Shino A., and Suzuoki Z. General survey of diabetic features of yellow KK mice. Endocrinol Jpn 17 (1970) 23-35
24. Graves D.T., Oskoui M., Volejnikova S., Naguib G., Cai S., Desta T., et al. Tumor necrosis factor modulates fibroblast apoptosis. PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res 80 (2001) 1875-1879
25. Leone C.W., Bokhadhoor H., Kuo D., Desta T., Yang J., Siqueira M.F., et al. Immunization enhances inflammation and tissue destruction in response to Porphyromonas gingivalis. Infect Immun 74 (2006) 2286-2292
26. Nishihara R., Sugano N., Takano M., Shimada T., Tanaka H., Oka S., et al. The effect of Porphyromonas gingivalis infection on cytokine levels in type 2 diabetic mice. J Periodontal Res 44 (2009) 305-310
27. Huang X., McClellan S.A., Barrett R.P., and Hazlett L.D. IL-18 contributes to host resistance against infection with Pseudomonas aeruginosa through induction of IFN-gamma production. J Immunol 168 (2002) 5756-5763
28. Hotamisligil G.S., Budavari A., Murray D., and Spiegelman B.M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α. J Clin Invest 94 (1994) 1543-1549
29. Cheung A.T., Wang J., Ree D., Kolls J.K., and Bryer-Ash M. Tumor necrosis factor-α induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes 49 (2000) 810-819
30. Ruan H., and Lodish H.F. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α. Cytokine Growth Factor Rev 14 (2003) 447-455
31. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389 (1997) 610-614
32. Yazdani-Biuki B., Stelzl H., Brezinschek H.P., Hermann J., Mueller T., Krippl P., et al. Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-α antibody infliximab. Eur J Clin Invest 34 (2004) 641-642
33. Gonzalez-Gay M.A., De Matias J.M., Gonzalez-Juanatey C., Garcia-Porrua C., Sanchez-Andrade A., Martin J., et al. Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 24 (2006) 83-86
34. Scott D.L., and Kingsley G.H. Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med 355 (2006) 704-712
35. Yazdani-Biuki B., Mueller T., Brezinschek H.P., Hermann J., Graninger W., and Wascher T.C. Relapse of diabetes after interruption of chronic administration of anti-tumor necrosis factor-α antibody infliximab: a case observation. Diabetes Care 29 (2006) 1712-1713
36. Liu R., Bal H.S., Desta T., Behl Y., and Graves D.T. Tumor necrosis factor-α mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing. Am J Pathol 168 (2006) 757-764